Skip to content

Medscape's Rare Edition

At Medscape, we are committed to shortening diagnostic journey and enabling the best possible care for people living with a rare disease.

We do this through a vast range of rare disease education and resources, available exclusively to our membership of over 13 million healthcare practitioners.

In the Medscape’s Rare Edition, you’ll find the latest updates on our rare disease projects, partnerships, insights, and innovations that are shaping the future of rare disease education. This page will be regularly updated with all our newsletters, so you can stay informed and engaged.

Sign up below to subscribe, or contact us to connect. We’d love to hear from you, and we’re always open to collaborations.

Together, we are stronger.

What's New?

The Impact of Rare Disease Education

In 2021, Medscape Education launched the Rare Diseases Learning Center, "Pathways in Rare Disease" This essential resource offers education and tools to empower clinicians in diagnosing and managing rare diseases. Created through global collaborations with leading rare disease organizations, professional societies, and patient advocacy groups, the center provides a rich learning environment.

The significant impact of this initiative is demonstrated by its reach and learners:

Activities icon

430

Activites

Stethascope Icon

3M

Learners

Clipboard icon

700K

Test Takers

As of Nov 2025

A Diagnostic Odyssey

For patients and parents of those living with a rare disease, the diagnostic journey is often long and fraught with hardship.

The moment they receive a diagnosis can be life-changing — that’s why we’re committed to sharing education to Shorten the Journey. Our short video, “A Diagnostic Odyssey,” highlights the anguish often felt, but also the power of diagnosis

Education has the Power to Reduce the Rare Disease Diagnostic Delay

We make the assumption that rare disease education has an impact in real world practice, leading to clinicians better recognizing red flags, ordering appropriate diagnostic tests and making a diagnosis. But where's the proof? That's what we sought to evaluate in these studies: are physicians who participate in accredited education (versus those who don't) more likely to order diagnostic tests? And are they more likely to code for rare disease diagnoses? Click on the posters below to find out.

Continuing Medical Education is Significantly Associated With Increased Rare Neurological, Endocrine and Liver Disease Diagnoses in Real World Practice

25_155-WODC_R4

Accredited Rare Disease Education Significantly Improves Knowledge, Competence, and Confidence Across Various Learning Needs

25_159-WODC_R2

Are Pediatric Neurologists Who Participate in Rare Disease  Education More Likely to Order Genetic Tests for Rare Diseases?

25_157-WODC_R2

Expert Voices in Rare Disease

Lucy

Lucy McKay, MD
CEO of Medics4RareDiseases, UK

The creation of this dedicated learning centre is a momentous step forward in the mission to educate medical professionals about rare diseases.
Providing accessible, reliable information about rare diseases is vital to help combat the 'diagnostic odyssey' sadly experienced by so many today.
Medscape is a hugely popular and trusted resource for doctors and its prioritisation of rare disease sends a big signal to the global medical community that rare disease is relevant, and it needs their attention.
 

Rare Disease Insights & Articles

Picture14
ARTICLE

Educational needs in diagnosing rare diseases: A multinational, multispecialty clinician survey

Read
Picture15
ARTICLE

Shining a light on rare cancers: the role of continuing medical education

Read
Picture13
ARTICLE

How women are revolutionising rare disease

Read
Picture10
ARTICLE

Rare disease education is key to enabling medics to achieve the best for their patients

Read
Picture12
ARTICLE

Rare diseases: making a difference through education

Read
Mrkt_3067_Women in Healthcare Podcast Cover
PODCAST

Pioneering Paths: Women Leadership in Rare Disease

Listen

Driving Change Together: Partnering with Leading Rare Disease Organizations

Unlock data-driven insights to inform your rare disease strategy